| Title
of the article |
ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations.
|
| Authors |
Mitterbauer C, Heinze G, Kainz A, Kramar R, Hörl WH, Oberbauer R. |
| Journal
|
Nephrol Dial Transplant. 2008 May;23(5):1742-6. Epub 2008 Jan 30. |
| Subject
Consultant |
B. Watschinger |
| Score
(1 to 3 stars) |
** |
| Comments |
In this large retrospective study ACEI/ARB therapy did not lead to relevant hyperkalaemia in renal transplant patients. |
